Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 285,658 |
|
|||||
| News | - | ||||||
| Day High | 100.26 | Low High |
|||||
| Day Low | 97.18 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Glaukos Corporation | GKOS | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.82 | -0.81% | 100.11 | 16:02:51 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 97.95 | 97.18 | 100.26 | 100.11 | 100.93 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,019 | 285,658 | $ 98.82 | $ 28,229,478 | - | 45.38 - 103.66 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:20:01 | formt | 2,181 | $ 100.11 | USD |
Glaukos Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.96B | 49.47M | - | 314.71M | -134.66M | -2.72 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Glaukos News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GKOS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 96.68 | 103.66 | 94.14 | 98.35 | 463,069 | 3.43 | 3.55% |
| 1 Month | 92.91 | 103.66 | 88.16 | 96.91 | 515,346 | 7.20 | 7.75% |
| 3 Months | 89.36 | 103.66 | 83.90 | 92.35 | 507,256 | 10.75 | 12.03% |
| 6 Months | 65.82 | 103.66 | 59.22 | 82.77 | 693,641 | 34.29 | 52.10% |
| 1 Year | 47.63 | 103.66 | 45.38 | 77.04 | 583,754 | 52.48 | 110.18% |
| 3 Years | 95.49 | 103.66 | 33.33 | 61.63 | 520,048 | 4.62 | 4.84% |
| 5 Years | 70.73 | 103.66 | 23.31 | 59.35 | 534,121 | 29.38 | 41.54% |
Glaukos Description
| Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure. |
